| 
    Sangamo And Bioverativ Announce FDA Acceptance Of IND Application For ST-400 
      Sangamo Therapeutics, Inc. the leader in therapeutic genome editing, and Bioverativ Inc. (NASDAQ: BIVV), a global biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapies for hemophilia and other rare blood disorders, announced today that the U.S. 
       | 
     | 
    A New International Conference On The Best Of Italian Track&Trace Technologies : The Marchesini Group And Sea Vision 
      On October 18th, the Marchesini Group, alongside SEA Vision - the Group’s longstanding Italian partner for vision systems for pharmaceutical and OEM industries - will be at the International Conference Industry 4.0: Trends in Pharma Manufacturing... 
       | 
     |